Sponsor:
The University of Texas Health Science Center at San Antonio
Code:
NCT06526104
Conditions
Hepatocellular Carcinoma
Cirrhosis, Liver
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tremelimumab
Durvalumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations